A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion.
The most commonly used animal models for evaluating the efficacy of HSV-2 candidate vaccines are mice and guinea pigs. While numerous HSV-2 vaccine candidates have been tested in these animals and were effective in reducing disease and mortality, these results did not predict the effectiveness of th...
Saved in:
| Main Authors: | Kening Wang, Tristan Jordan, Kennichi Dowdell, Richard Herbert, Ian N Moore, David M Koelle, Jeffrey I Cohen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-09-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1012477 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunity to Ocular and Genital Herpes Simplex Viruses Infections
by: Aziz Alami Chentoufi, et al.
Published: (2012-01-01) -
Predeominace of Herpes Simplex Virus Type 1 from Patients with Genital Herpes in Nova Scotia
by: Kevin R Forward, et al.
Published: (2003-01-01) -
Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine.
by: William P Halford, et al.
Published: (2010-08-01) -
Leflunomide in the Treatment of a Pseudotumoral Genital Herpes Simplex Virus Infection in an HIV Patient
by: Marie R. Roger, et al.
Published: (2017-01-01) -
Herpes Simplex Virus Encephalitis
by: J Gordon Millichap
Published: (1992-04-01)